Lutathera® (lutetium [177Lu] oxodotreotide)

Where can I get more information about Lutathera®?

Summary of product characteristics (SmPC)

Patient information leaflet (PIL)

These links will take you to the electronic medicines compendium (emc) websites, which are not Novartis websites.

 

NCUK patient support leaflet

 

Pluvicto®▼ (lutetium [177Lu] vipivotide tetraxetan)

Where can I get more information about Pluvicto®?

Summary of product characteristics (SmPC)

Patient information leaflet (PIL)

These links will take you to the electronic medicines compendium (emc) websites, which are not Novartis websites.

 

Reporting side-effects
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the information leaflet that comes in the pack.
The medicine referred to in this material is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Please see www.mhra.gov.uk/yellowcard for instructions on how to report side effects.

UK | FA-11331062 | February 2025
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.